30 SEP - 1 OCT 2021

Registrations are Now Closed


30 SEP - 1 OCT 2021

11:00 – 18:30 CET

Click here to mark your calendars now



Participate from wherever you are



Planova users & Key industry leaders



Share experience and gain new insights

About the Event

Dear Valued Customers,

Hopefully, you and your families are healthy and safe during these uncertain and unprecedented times!

The COVID-19 pandemic has caused an immense change to our daily lives and it also continues to define our new normal. This is a challenge we must overcome together in cooperation and mutual responsibility. Taking into account the health and safety of our customers and our staff, we recognized that organizing physical events is still too high of a risk. In this regard, we would like to inform you that we have decided to organize the PlanovaTM Workshop as 2021 PLANOVATM EU VIRTUAL SYMPOSIUM.

Our eminent speakers and users of Planova virus removal filters will share their experiences in downstream process development and the manufacturing of biopharmaceuticals. It will be an outstanding opportunity to gain new insights and learn about the advanced technology that can improve your processes. Our global Planova Team will provide you with an exclusive view into our product pipeline and services.



Opening And Access To The Virtual Exhibition Area


Opening Remarks

Ken Shinomiya
Director and Senior Executive Officer, Head of Bioprocess Division, Asahi Kasei Medical

Session A: Fundamentals And Regulatory

CHAIR: Thomas R. Kreil, PhD
Vice President, Global Pathogen Safety, Associate Professor of Virology, Takeda

The Emergence Of SARS-CoV-2 And Virus Antibodies In IG Products

Thomas R. Kreil, PhD
Vice President, Global Pathogen Safety, Associate Professor of Virology, Takeda

Revision Of Guideline ICHQ5A

Johannes Blumel, PhD
Head of Virus Safety Section, Paul-Ehrlich-lnstitut

Viral Safety Of Biologics In The 2020s - A Preview

Horst Ruppach, PhD
Executive Director, Scientific And Portfolio, Global Biologics, Charles River Laboratories

Strategies For Controlling Virus Risk In Upstream Processes

Andy Bailey, PhD
CEO & Operations Director, ViruSure

Coffee Break - Access To The Virtual Exhibition Area
Session B: Virus Filtration With Plasma Proteins

CHAIR: Salvador Grancha, PhD
R&D Vicepresident, Grifols

Contribution To The Global Virus Safety Against Emerging Viruses

Sebastian Teitz, PhD
Scientific Coordinator, Asahi Kasei Bioprocess Europe

Nanofiltration Strategies In Plasma Protein Process Development

Merche Faro, PhD
R&D New Process Development Senior Manager, Scientific Innovation Office, Grifols

Filter Replacement In RhoGAM® Manufacturing Process

Natalia Ugulava, PhD
Sr. Scientist, Kedrion Biopharma

Impact Of Protein Fouling On Virus Retention In Planova 20N Membranes

Remo Leisi, PhD
Senior Manager, Translational Research and Innovation, Global Pathogen Safety, CSL Behrin

Virtual Show And Access To The Virtual Exhibition Area


Opening And Access To The Virtual Exhibition Area



Session C: Robust Biomanufacturing

CHAIR: Uwe Gottschalk, PhD
Chief Scientific Officer, Lonza

Advancing Bioprocess Operations From Pressure To Pump: Robustness Of Pump Based Virus Filtration, Including Pressure Ramp-Up Phase

Daniel Strauss, PhD
R&D Director, Asahi Kasei Bioprocess America

Integration Of Planova 20N In A CDMO Process Development Project: Risk Mitigation Approach For Viral Clearance With A Non-GLP Pre-Study

Audrey Cousinet
Head of Downstream Process Development, GTP Biologics

Efficient Viral Removal At High Protein Concentration Load By BioEX Nanofilter

Ayelet Cooper, PhD
Process Development Manager, R&D, KinBio

Operation Of A Continuous Biomanufacturing Platform For Production Of A Monoclonal Antibody At 500 L-Scale

Carmen Heeran
Principal Research Scientist, Downstream Process Development, FUJIFILM Diosynth Biotechnologies

Coffee Break - Access To The Virtual Exhibition Area
Session D: New Technologies And Trends

CHAIR: Nathan J. Roth, PhD
Vice President, PPD Bern, CMC and Global Patogen Safety, R&D, CSL Behring

Direct Visualization Of Virus Removal Process In Hollow Fiber Membrane Using An Optical Microscope

Takayuki Nishizaka, PhD
Professor, Department of Physics, Gakushuin University

Lentiviral Vectors Purification: Improving Current Processes And Exploring New Strategies

Sofia Moreira, PhD Student
Downstream Processes Lab, Animal Cell Technology Unit, iBET

Upstream Filtration Of Medias For ATMPs

Jonas Thomsen, PhD
Development Scientist, Novo Nordisk

New Product Introduction & Closing Remarks

Masashi Yamamoto, PhD
Technical Director, Asahi Kasei Bioprocess Europe

Access To The Virtual Exhibition Area